Intel's stock downgraded by Goldman Sachs
Goldman Sachs is taking a bearish view on the chipmaker Intel (NASDAQ:INTC) as its analyst Toshiya Hari has slashed his position on the stock to Sell from Neutral and its 12-month price target to US$44 from US$49.
In a note to investors, Hari argues that Intel’s struggles with 10-nanometer process technology will have consequences for its ability to battle against its rival Taiwan Semiconductor Manufacturing Co (NYSE:TSM) and other chipmakers as well as its ability to sustain its margins and grow earnings.
Read: Intel CEO steps down amid investigation into past relationship with an employee
“We believe Intel’s manufacturing issues could potentially be deeper-rooted than what most think and could have a sustained impact on market share and/or spending levels as Intel competes with a growing/stronger Taiwan Semiconductor Manufacturing Company eco-system,” Hari wrote.
Goldman analysis suggests that between 2017 and 2020, Taiwan Semiconductor Manufacturing Company will grow its research and development at an 8% compound annual growth rate compared to just a 5% CAGR for Intel.
Competition from rivals may prove too much for Intel
Hari is particularly concerned about Intel’s ability to fend off further competition from Advanced Micro Devices, Xilinx, Nvidia and its own customers like Google which are now producing their own chips.
“We are sell-rated on Intel based on concerns around the company’s process technology roadmap, increased competition from Advanced Micro Devices, Xilinx, Nvidia, startups and its own customers (i.e. companies including Google, who are now producing their own chips to address their compute needs),” he wrote in his note.
In addition to concerns about revenue, Goldman analysts also see risks to gross margins due to Intel’s growing mix of lower-margin revenue as well as increased pricing pressure resulting from competition and “higher, go-forward” depreciation.
Goldman would consider adopting a more positive stance on Intel if the chip maker were to refocus its portfolio by divesting its non-core assets or by reducing its investment in areas where Intel is not having much success.
Intel shares were flat in pre-market trade at US$49.16.
Story by ProactiveInvestors
Source: http://www.proactiveinvestors.com/companies/news/202762/intel-s-stock-downgraded-by-goldman-sachs-202762.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video).